Inhibikase Therapeutics Overview

Inhibikase Therapeutics Gross Profit

Gross Profit analysis for IKT.

Quarterly Gross Profit

N/A

As of Mar 31, 2026

Annual Gross Profit (TTM)

$-84656.00

↑ 1188.72% YoY

Trailing 12 months ending Mar 31, 2026

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin